Is it Time to Dump CV Sciences Inc (CVSI) Stock After it Is Lower By 20.00% in a Week?

CV Sciences Inc (CVSI) stock is down 20.00% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

CV Sciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CVSI!

See Full CVSI Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With CVSI Stock Today?

CV Sciences Inc (CVSI) stock is unchanged 3.59% while the S&P 500 is lower by -1.03% as of 12:40 PM on Thursday, Sep 21. CVSI is flat $0.00 from the previous closing price of $0.04 on volume of 261,035 shares. Over the past year the S&P 500 is up 12.99% while CVSI is flat 0.00%. CVSI earned $0.01 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 6.43. To screen for more stocks like CV Sciences Inc click here.

More About CV Sciences Inc

CV Sciences Inc is a pharmaceutical company. The group operates in two segments consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures and markets products based on hemp-based Cannabidiol (CBD). Whereas the specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient. Click Here to get the full Stock Report for CV Sciences Inc stock.